Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.

Metabolism: clinical and experimental - 1 Dec 2012

Atkinson Charlotte, Newton Katherine M, Yong Mellissa, Stanczyk Frank Z, Westerlind Kim C, Li Lin, Lampe Johanna W

Abstract excerpt

BACKGROUND: Bone density has been suggested as a marker of cumulative hormone exposure. Small studies also suggest that patterns of daidzein metabolism may be related to hormone concentrations. To our knowledge, no studies in premenopausal women have compared bone density by daidzein-metabolizing phenotypes in the absence of a soy intervention. OBJECTIVE: The objective was to evaluate the relationship between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Absorptiometry, Photon
Share to Body Composition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Femur Neck

Share to Glycine max

Share to Isoflavones

Share to Lumbar Vertebrae

Share to Premenopause

Source

Open in PubMed Open full text

Identifiers

PMID: 22819530
DOI: 10.1016/j.metabol.2012.05.012
PMCID: PMC3504616

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.PMID 22819530Read ↗

Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.Semantic proximity Read ↗

Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States.Semantic proximity Read ↗

Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.Semantic proximity Read ↗

Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.Semantic proximity Read ↗

Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.Semantic proximity Read ↗

Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.Semantic proximity Read ↗

Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls.Semantic proximity Read ↗

Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.Semantic proximity Read ↗

Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China.Semantic proximity Read ↗

Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.Semantic proximity Read ↗

Cardiovascular disease risk factors in women with O-desmethylangolensin producing and non-producing gut microbial metabotypes: an observational study.Semantic proximity Read ↗

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.